GL1X · GenesisL1 explorer

Research workbench

The C145A mutant of the amidase from nesterenkonia sp. AN1 in complex with butyramide

Analyse The C145A mutant of the amidase from nesterenkonia sp. AN1 in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4IZS
Type
protein
Length
261 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Amidase
EC
3.5.1.4
UniProt
D0VWZ1
Ligands
BMD
Pockets
2 · best druggability 0.38

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAmidase (EC 3.5.1.4)protein26135% helix, 26% strandD0VWZ1

Ligands and binding sites

  • BMD · Butyramide · ligand · chains A
  • PEG · Di(hydroxyethyl)ether · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1600.380.7922BMD
2550.270.7411empty

Compared structures

  • 4IZS · The C145A mutant of the amidase from Nesterenkonia sp. AN1 in complex with butyramide · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.